|
Volumn 68, Issue 1, 2002, Pages 59-65
|
Does SSRI augmentation with antidepressants that influence noradrenergic function resolve depression in obsessive-compulsive disorder?
|
Author keywords
Augmentation; Comorbidity; Depression; Obsessive compulsive disorder; Treatment
|
Indexed keywords
ANTIDEPRESSANT AGENT;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE COURSE;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG EFFECT;
FEMALE;
HUMAN;
MALE;
NORADRENERGIC SYSTEM;
OBSESSION;
PRIORITY JOURNAL;
SAMPLE SIZE;
TREATMENT FAILURE;
TREATMENT INDICATION;
ADULT;
COMORBIDITY;
DEPRESSIVE DISORDER;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
OBSESSIVE-COMPULSIVE DISORDER;
SEROTONIN UPTAKE INHIBITORS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 0036178724
PISSN: 01650327
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-0327(00)00326-8 Document Type: Article |
Times cited : (12)
|
References (18)
|